AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,008.00p
   
  • Change Today:
      39.00p
  • 52 Week High: 13,276.00p
  • 52 Week Low: 9,501.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.30m
  • Volume: 1,064,162
  • Market Cap: £155,154m
  • RiskGrade: 123
  • Beta: 0.87

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
78.96% above the market average78.96% above the market average78.96% above the market average78.96% above the market average78.96% above the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average
1yr Revenue Growth
10.54% below the market average10.54% below the market average10.54% below the market average10.54% below the market average10.54% below the market average
31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
38.62% below the market average38.62% below the market average38.62% below the market average38.62% below the market average38.62% below the market average
Sector averageSector averageSector averageSector averageSector average
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
80.7% below the market average80.7% below the market average80.7% below the market average80.7% below the market average80.7% below the market average
39.53% below the sector average39.53% below the sector average39.53% below the sector average39.53% below the sector average39.53% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
79.53% below the market average79.53% below the market average79.53% below the market average79.53% below the market average79.53% below the market average
56% below the sector average56% below the sector average56% below the sector average56% below the sector average56% below the sector average
Price Chg 3m
70.79% below the market average70.79% below the market average70.79% below the market average70.79% below the market average70.79% below the market average
52% below the sector average52% below the sector average52% below the sector average52% below the sector average52% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
69.4% below the market average69.4% below the market average69.4% below the market average69.4% below the market average69.4% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average
Momentum 20
99.86% below the market average99.86% below the market average99.86% below the market average99.86% below the market average99.86% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
34.36% above the market average34.36% above the market average34.36% above the market average34.36% above the market average34.36% above the market average
88.89% above the sector average88.89% above the sector average88.89% above the sector average88.89% above the sector average88.89% above the sector average
ROCE
75.93% above the market average75.93% above the market average75.93% above the market average75.93% above the market average75.93% above the market average
7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
98.12% above the market average98.12% above the market average98.12% above the market average98.12% above the market average98.12% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Forecast EPS
97.24% above the market average97.24% above the market average97.24% above the market average97.24% above the market average97.24% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
98.70% above the market average98.70% above the market average98.70% above the market average98.70% above the market average98.70% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Operating Profit Loss
98.85% above the market average98.85% above the market average98.85% above the market average98.85% above the market average98.85% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
96.88% above the market average96.88% above the market average96.88% above the market average96.88% above the market average96.88% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Cash
97.64% above the market average97.64% above the market average97.64% above the market average97.64% above the market average97.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
90.05% above the market average90.05% above the market average90.05% above the market average90.05% above the market average90.05% above the market average
92.31% above the sector average92.31% above the sector average92.31% above the sector average92.31% above the sector average92.31% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
2.76% above the market average2.76% above the market average2.76% above the market average2.76% above the market average2.76% above the market average
6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average
Brokers Percent Neutral
64.91% below the market average64.91% below the market average64.91% below the market average64.91% below the market average64.91% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,008.00p
Change Today 39.00p
% Change 0.39 %
52 Week High 13,276.00p
52 Week Low 9,501.00p
Volume 1,064,162
Shares Issued 1,550.30m
Market Cap £155,154m
Beta 0.87
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
87.66% below the market average87.66% below the market average87.66% below the market average87.66% below the market average87.66% below the market average
88% below the sector average88% below the sector average88% below the sector average88% below the sector average88% below the sector average
Price Trend
27.11% below the market average27.11% below the market average27.11% below the market average27.11% below the market average27.11% below the market average
34.69% above the sector average34.69% above the sector average34.69% above the sector average34.69% above the sector average34.69% above the sector average
Income
78.05% below the market average78.05% below the market average78.05% below the market average78.05% below the market average78.05% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Growth
88.44% above the market average88.44% above the market average88.44% above the market average88.44% above the market average88.44% above the market average
94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average

What The Brokers Say

Strong Buy 9
Buy 15
Neutral 5
Sell 0
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 08-Aug-24 22-Feb-24
Paid 09-Sep-24 25-Mar-24
Amount 100.00¢ 197.00¢

Trades for 21-Nov-2024

Time Volume / Share Price
12:40 28 @ 10,008.00p
12:40 23 @ 10,008.00p
12:40 64 @ 10,008.00p
12:40 99 @ 10,009.20p
12:39 12 @ 10,008.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page